Literature DB >> 11819027

Effect of paroxetine on extracellular serotonin and dopamine levels in the prefrontal cortex.

Kazuhiko Nakayama1.   

Abstract

Abstract. Paroxetine, a selective serotonin (5-HT) reuptake inhibitor, increased extracellular 5-HT and dopamine levels, as determined by microdialysis, in the medial prefrontal cortex (mPFC) of freely moving rats. There was a difference in the time course of the maximum response between the 5-HT and dopamine levels after paroxetine administration. The extracellular dopamine concentration reached its maximum 20 min after the peak effect of 5-HT had appeared. The paroxetine-induced increase in extracellular dopamine concentration, but not 5-HT concentration, was inhibited by the 5-HT(3)-receptor antagonist granisetron. These results suggest that the increase in extracellular dopamine concentration in the mPFC elicited by paroxetine is the result of stimulation of 5-HT(3) receptors by the extracellular accumulation of 5-HT in the mPFC.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11819027     DOI: 10.1007/s00210-001-0497-7

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  The paroxetine effect on exercise performance depends on the aerobic capacity of exercising individuals.

Authors:  Francisco Teixeira-Coelho; João Paulo Uendeles-Pinto; Ana Cláudia Alves Serafim; Samuel Penna Wanner; Márcio de Matos Coelho; Danusa Dias Soares
Journal:  J Sports Sci Med       Date:  2014-05-01       Impact factor: 2.988

Review 2.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

3.  Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats.

Authors:  Jenny C E Owen; Peter S Whitton
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  A new strategy for antidepressant prescription.

Authors:  Francis Lavergne; Thérèse M Jay
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

5.  Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.

Authors:  John F Cryan; Olivia F O'Leary; Sung-Ha Jin; Julie C Friedland; Ming Ouyang; Bradford R Hirsch; Michelle E Page; Ashutosh Dalvi; Steven A Thomas; Irwin Lucki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

6.  Differential interactions of desipramine with amphetamine and methamphetamine: evidence that amphetamine releases dopamine from noradrenergic neurons in the medial prefrontal cortex.

Authors:  James R Shoblock; Isabelle M Maisonneuve; Stanley D Glick
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

7.  Social defeat stress-specific increase in c-Fos expression in the extended amygdala in mice: Involvement of dopamine D1 receptor in the medial prefrontal cortex.

Authors:  Chisato Numa; Hirotaka Nagai; Masayuki Taniguchi; Midori Nagai; Ryota Shinohara; Tomoyuki Furuyashiki
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

8.  Decreased Brain Ventricular Volume in Psychiatric Inpatients with Serotonin Reuptake Inhibitor Treatment.

Authors:  P K Bolin; S N Gosnell; K Brandel-Ankrapp; N Srinivasan; A Castellanos; R Salas
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-07-14

9.  Psychiatric medication and physical performance parameters - Are there implications for treatment?

Authors:  Anna Hirschbeck; Douglas Silva Leao; Elias Wagner; Alkomiet Hasan; Astrid Roeh
Journal:  Front Psychiatry       Date:  2022-09-06       Impact factor: 5.435

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.